Stem Point Capital LP Bridge Bio Pharma, Inc. Transaction History
Stem Point Capital LP
- $314 Billion
- Q1 2025
A detailed history of Stem Point Capital LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Stem Point Capital LP holds 208,437 shares of BBIO stock, worth $7.03 Million. This represents 2.3% of its overall portfolio holdings.
Number of Shares
208,437Holding current value
$7.03 Million% of portfolio
2.3%Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
351Shares Held
186MCall Options Held
13.4MPut Options Held
1.98M-
Viking Global Investors LP22.1MShares$744 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$650 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$503 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$420 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$242 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...